The largest database of trusted experimental protocols

17 protocols using t7 rna polymerase

1

Droplet-Based In Vitro Transcription

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR droplets were reinjected and spaced into a fusion device at a rate of ∼1500 droplets/sec. Each PCR droplet was then synchronized with a 16 pL IVT droplet containing 2 mM each NTP (Larova), 25 mM MgCl2, 44 mM Tris-HCl pH 8.0 (at 25°C), 5 mM DTT, 1 mM Spermidine, 0.1% of Pluronic F68 (Sigma-Aldrich), 1 µg of pyrophosphatase (Roche), 500 nM Gemini-561, 1 µM coumarin acetate (Sigma-Aldrich) and 17.5 µg/mL T7 RNA polymerase (purified in the laboratory). IVT mixture was loaded in a length of PTFE tubing and kept on ice during all the experiment. PCR droplets were spaced and IVT droplets produced using a dedicated stream of Novec 7500 fluorinated oil (3M) supplemented with 2% (w/w) of fluorosurfactant. Flowrates (MFCS, Fluigent) were adjusted to generate 16 pL IVT droplets and maximize synchronization of 1 PCR droplet with 1 IVT droplet. Pairs of droplets were then fused with an AC field (400 V at 30 kHz) and the resulting emulsion was collected off-chip and incubated for 2 h at 37°C.
+ Open protocol
+ Expand
2

Identifying ODIR1 RNA Interacting Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full length ODIR1 RNA (ODIR1) and ODIR1-antisense RNA (ODIR1-AS) were transcribed in vitro from pcDNA3.1-ODIR1 and pcDNA3.1-ODIR1-AS and labeled with biotin by the Biotin RNA Labeling Mix (Sigma, USA) and T7 RNA polymerase (Sigma, USA). The biotin-labeled RNAs (3 μg) was subjected to heat shock at 90 °C for 2 min and cooled at room temperature (about 25.0 °C) for 20 min, folded with RNA structure buffer, then mixed with cell extract of hUC-MSCs, incubated with Streptavidin Agarose Resin (Thermo Fisher Scientific Inc., Waltham, MA, USA) at 4 °C for 2 h and washed. The retrieved proteins were subjected to SDS-PAGE gel electrophoresis and the protein band of the ODIR1 group was subjected to silver staining, and differential protein bands were identified using high resolution mass spectrometry (LC-LTQ-Orbitrap; Thermo Fisher Scientific, Waltham, MA, USA). The identified proteins were examined using regular western blotting assay. The GO functional annotation was analyzed using the Gene Ontology Consortium (http://www.geneontology.org/).
+ Open protocol
+ Expand
3

Hv_Wnt3a and Hv_Bra1 Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Digoxigenin-labeled RNA probes for Hv_Wnt3a and Hv_Bra1 were prepared by in vitro transcriptions from templates amplified from a recombinant pCR BluntII TOPO (Invitrogen) plasmids containing the Hv_Wnt3a and Hv_Bra1 cDNA using PCR. (DIG Labeling Mix—Sigma—1277073910; SP6 RNA Polymerase—Sigma—10810274001; T7 RNA Polymerase—Sigma—10881767001). Whole-mount in situ hybridization was performed on the polyps as described [92 (link)] with the following changes. Treatment with proteinase-K was performed for 5 min and heat-inactivation of the endogenous alkaline phosphatases was done at 70 °C for 15 min in 1X SSC. Digoxigenin-labeled RNA probe at a concentration of 150 ng/ml was used for hybridization at 59 °C. The post-hybridization washes were performed using 1X SSC-HS gradients. After staining with 50% NTMT/50% BM-purple AP substrate for 1 h at room temperature, the animals were mounted in 80% glycerol for imaging. Imaging was performed using Olympus MVX10 stereomicroscope.
+ Open protocol
+ Expand
4

SARS-CoV-2 Gene Fragment Synthesis and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each region, ~ 500 bp gene fragments for ORF1ab (NC_045512.2: 416–931 and 12,869–13,388) and N gene (NC_045512.2: 28,246–28,747) were synthesised with an additional 100 bp up and downstream of the target region (ThermoFisher) (Supplementary Table 2). Each fragment contained a T7 promoter for transcription and M13 adapters for amplification. Seven DNA standards from synthesised gene fragments were prepared for ORF1ab (100,000, 10,000, 5000, 1000, 500, 250 and 100 copies/µl) while eight DNA standards were prepared for the N gene (100,000, 10,000, 5000, 1000, 500, 250, 100 and 10 copies/µl).
For RNA, 1 pg of synthesised gene fragments were transcribed overnight at 37 °C using T7 RNA polymerase (Sigma). Overnight DNA digestion was performed using the turbo DNA free kit (ThermoFisher) and further treated with DNase I (NEB) until all traces of DNA were removed. Complete DNA removal was confirmed after each round of DNase treatment using rt-PCR with the SensiFAST SYBR kit (Bioline) and F1/R1 MCDA primers (Supplementary Table 1). The transcribed RNA was serially diluted and used as input. Since the amount of RNA transcribed was below the 250 pg/µl limit of detection for Qubit HS RNA assay (ThermoFisher), the input RNA copy number could not be determined. Therefore, the lowest detectable dilutions were used for sensitivity comparison.
+ Open protocol
+ Expand
5

Time-course analysis of Bra1 expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydra polyps were treated with target inhibitors for 8 h and decapitated. After decapitation, the inhibitor treatment continued until the target time points of 1, 2, 4, and 8 hpa. The polyps were then relaxed by treatment with 2% urethane/HM for 2 min and fixed using 4% PFA/HM at 4°C overnight. Digoxigenin-labelled RNA probes for Hv_Bra1 were prepared by in vitro transcriptions from templates amplified from a recombinant pCR Blunt II TOPO (Cat # 450031; Invitrogen) plasmid containing the Hv_Bra1 gene using PCR. (DIG Labelling Mix, Cat # 1277073910; Sigma-Aldrich; SP6 RNA Polymerase, Cat # 10810274001; Sigma-Aldrich; T7 RNA Polymerase, Cat # 10881767001; Sigma-Aldrich). Whole-mount in situ hybridization was performed on the polyps as described previously (Martinez et al, 1997 (link)) with the following changes. Treatment with proteinase-K was performed for 5 min, and heat inactivation of the endogenous alkaline phosphatases was done at 70°C for 15 min in 1X SSC. Digoxigenin-labelled RNA probe at a concentration of 150 ng/ml was used for hybridization at 59°C. The post-hybridization washes were performed using 1X SSC-HS gradients. After staining with 50% NTMT/50% BM-purple AP substrate for 1 h at room temperature, the animals were mounted in 80% glycerol for imaging.
+ Open protocol
+ Expand
6

In Vitro Transcription of RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each IVT reaction was set up with 50 nM of linearized DNA template, 5 mM of each ATP, CTP, UTP, 9 mM of GTP (NEB, Ipswitch, MA), 0.004 unit/μL of thermostable inorganic pyrophosphatase (NEB, Ipswitch, MA), 0.25 μg/μL T7 RNA polymerase, 0.05% Triton X-100 (Sigma, St. Louis, MO) and 1 unit/μL RNase Inhibitor, Murine (NEB, Ipswitch, MA). The IVT reaction was carried out at 37 °C for 4 hours to allow for sufficient RNA synthesis. To remove DNA template, 2 μL of 100 mM CaCl2 and 20 units of Turbo DNase (Life Technologies, Carlsbad, CA) were added to the mixture and incubated at 37 °C for 1 hour. The mixture was then centrifuged at 10,000 RCF for 5 minutes at room temperature to pellet any remaining magnesium pyrophosphate. The supernatant was resuspended in 50 μL RNase free water, followed by 12% denaturing PAGE purification. Purified IVT products were stored at −80°C until used.
+ Open protocol
+ Expand
7

In Vitro Transcription of Pre-miRNAs and Labeling of RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, pre-miR-664a, pre-miR-664a-U1A, and pre-miRNA-U1A control (non-targeting pre-miRNA containing the U1A recognition sequence) were prepared by in vitro transcription. To generate DNA templates for transcription, primer extension was performed using 2 µM of each primer (shown in Table S1) in a reaction mixture containing KOD Dash DNA polymerase (TOYOBO, Osaka, Japan). The resulting template DNA was precipitated with 2-propanol. T7 RNA polymerase was prepared as described previously21 (link). The transcription reaction was carried out at 37 °C for 4 h in a reaction mixture containing 40 mM Tris–HCl (pH 8.0), 24 mM MgCl2, 5 mM dithiothreitol, 10 mM guanosine monophosphate, 2 mM of each NTP, 1.8 U/mL inorganic pyrophosphatase (Sigma, St. Louis, MO, USA), 26.2 µg/mL purified T7 RNA polymerase, and 10 µg/mL DNA template. The pre-miRNA transcripts were purified using an 8% denaturing polyacrylamide gel. All pre-miRNAs were renatured by incubating for 1 min at 85 °C, followed by slow cooling to 4 °C.
The FAM-labeled RNA (RNA-FAM) was purchased from Hokkaido System Science (Hokkaido, Japan). The RNA-FAM sequence was as follows: 5′-GAU UAU GUC CGG UUA UGU ACA UUG CAC UCC GUA CAU AAC CGG ACA UAA UCdT dT-FAM-3′ (the U1A binding sequence is underlined).
+ Open protocol
+ Expand
8

PVT1 RNA Pulldown Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PVT1 was in vitro transcribed with T7 RNA polymerase (Sigma, 18033019), biotin-labeled with the Biotin RNA Labeling Mix (Thermo Scientific, 89818), treated with RNase-free DNase I (Invitrogen, AM2224), and purified with an RNeasy Mini Kit (Qiagen, 74104). The following RNA-pulldown experiment was carried out according to the instructions (Thermo Scientific, 20164).
+ Open protocol
+ Expand
9

In vitro Transcription of DvSnf7 RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vitro T7 RNA Polymerase-transcribed 968 nucleotide (nt) DvSnf7 RNA (IVT DvSnf7 RNA) was used to treat soil samples and serve as the reference standard for the QuantiGene 2.0 microplate assay [24] (link). This 968-nt transcript is produced in transgenic maize containing a DvSnf7 suppression cassette and was determined by cDNA sequencing to include a 240-nt inverted repeat region and adjacent 5′- and 3′ sequences. The 968-nt DvSnf7 fragment was amplified by PCR from the original plant transformation vector and cloned downstream of a synthetic T7 promoter sequence (TAATACGACTCACTATAGGG) in pUC19 plasmid. The identity of the recombinant pUC plasmid template used to produce the IVT DvSnf7 RNA was verified by DNA sequencing. For IVT RNA synthesis, the pUC plasmid was linearized by BglII restriction digestion and incubated with nucleoside triphosphates (8 mM each, Sigma) and T7 RNA Polymerase in transcription buffer overnight at 37°C. The reaction was then treated with DNase I (100 units per 1 mL, Ambion) and extracted with phenol∶chloroform (1∶1 volume∶volume). The size of the IVT DvSnf7 RNA was confirmed by agarose gel electrophoresis and its concentration was determined using a NanoDrop 8000 (Thermo Scientific, Wilmington, DE) according to the manufacturer's instruction. Aliquots of the IVT DvSnf7 RNA sample were stored in a −80°C freezer.
+ Open protocol
+ Expand
10

Transcription and Purification of TPP Riboswitch

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transcription templates were prepared by PCR amplification from a plasmid-borne gene for the TPP riboswitch using primers hybridizing to the T7 promoter and the 3′-end of the riboswitch. RNA was transcribed from 75 μg/ml DNA template in 30 mM Tris–HCl (pH 8.0), 10 mM DTT, 0.1% Triton X-100, 0.1 mM spermidine–HCl, 4 mM each NTP (Sigma; pH adjusted to 8.0), 40 mM MgCl2, 50 μg/ml T7 RNA polymerase, 1 U/ml inorganic pyrophosphatase (Sigma), for 3 to 3.5 h at 37°C. The products were purified by gel electrophoresis under denaturing conditions. RNA was extracted from gel slices by electroelution and exchanged five times into 40 mM K-Hepes (pH 7.5), 100 mM KCl, 10 mM MgCl2 for ITC analysis, or 25 mM Tris, 192 mM glycine (pH 8.3), 1 mM MgCl2 for analysis by gel electrophoresis. Concentrations were measured by absorbance at 260 nm using extinction coefficients calculated from the nucleotide composition and a hypochromic effect correction factor.
The sequence (written 5′ to 3′) of the unmodified E. coli TPP riboswitch was:
GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!